Literature DB >> 29550192

Immune response elicited by two rBCG strains devoid of genes involved in c-di-GMP metabolism affect protection versus challenge with M. tuberculosis strains of different virulence.

Cristian Alfredo Segura-Cerda1, Michel de Jesús Aceves-Sánchez1, Brenda Marquina-Castillo2, Dulce Mata-Espinoza2, Jorge Barrios-Payán2, Perla Jazmín Vega-Domínguez1, César Pedroza-Roldán3, Jorge Bravo-Madrigal1, Alba Adriana Vallejo-Cardona1, Rogelio Hernández-Pando2, Mario Alberto Flores-Valdez4.   

Abstract

Pellicles, a type of biofilm, have gathered a renewed interest in the field of tuberculosis as a structure that mimics some characteristics occurring during M. tuberculosis infection, such as antibiotic recalcitrance and chronicity of infection, and as a source of antigens for humoral response in infected guinea pigs. In other bacteria, it has been well documented that the second messenger c-di-GMP modulates the transition from planktonic cells to biofilm formation. In this work, we used the live vaccine Mycobacterium bovis BCG to determine whether deletion of genes involved in c-di-GMP metabolism would affect interaction with macrophages, capacity to induce immune response in a murine cell line and mice, and how the protein profile was modified when grown as surface pellicles. We found that deletion of the BCG1419c (Delta c-di-GMP phosphodiesterase, ΔPDE) gene, or deletion of the BCG1416c (Delta c-di-GMP diguanylate cyclase, ΔDGC) gene, altered production of TNF-α, IL-6, and IL-1β, in murine macrophages, and resulted in attenuation in intra-macrophage replication. Moreover, in addition to the improved immunogenicity of the BCGΔBCG1419c mutant already reported, deletion of the BCG1416c gene leads to increased T CD4+ and T CD8+ activation. This correlated with protection versus lethality in mice infected with the highly virulent M. tuberculosis 5186 afforded by vaccination with all the tested BCG strains, and controlled the growth of the mildly virulent M. tuberculosis H37Rv in lungs by vaccination with BCGΔBCG1419c during chronic late infection from 4 to 6 months after challenge. Furthermore, when grown as surface pellicles, a condition used to manufacture BCG vaccine, in comparison to BCG wild type, both rBCGs changed expression of antigenic proteins such as DnaK, HbhA, PstS2, 35KDa antigen, GroEL2, as well as AcpM, a protein involved in synthesis of mycolic acids, molecules relevant to modulate inflammatory responses.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  BCG; Cytokines; Pellicle; Proteome; T-cell activation; Tuberculosis

Mesh:

Substances:

Year:  2018        PMID: 29550192     DOI: 10.1016/j.vaccine.2018.03.014

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  9 in total

1.  BCG and BCGΔBCG1419c protect type 2 diabetic mice against tuberculosis via different participation of T and B lymphocytes, dendritic cells and pro-inflammatory cytokines.

Authors:  Cristian Alfredo Segura-Cerda; Brenda Marquina-Castillo; Vasti Lozano-Ordaz; Dulce Mata-Espinosa; Jorge Alberto Barrios-Payán; Manuel O López-Torres; Michel de Jesús Aceves-Sánchez; Helle Bielefeldt-Ohmann; Rogelio Hernández-Pando; Mario Alberto Flores-Valdez
Journal:  NPJ Vaccines       Date:  2020-03-12       Impact factor: 7.344

2.  The BCGΔBCG1419c Vaccine Candidate Reduces Lung Pathology, IL-6, TNF-α, and IL-10 During Chronic TB Infection.

Authors:  Mario A Flores-Valdez; César Pedroza-Roldán; Michel de Jesús Aceves-Sánchez; Eliza J R Peterson; Nitin S Baliga; Rogelio Hernández-Pando; JoLynn Troudt; Elizabeth Creissen; Linda Izzo; Helle Bielefeldt-Ohmann; Thomas Bickett; Angelo A Izzo
Journal:  Front Microbiol       Date:  2018-06-12       Impact factor: 5.640

3.  BCG Vaccination Prevents Reactivation of Latent Lymphatic Murine Tuberculosis Independently of CD4+ T Cells.

Authors:  Harindra D Sathkumara; Saparna Pai; Michel de Jesús Aceves-Sánchez; Natkunam Ketheesan; Mario Alberto Flores-Valdez; Andreas Kupz
Journal:  Front Immunol       Date:  2019-03-21       Impact factor: 7.561

4.  Viromimetic STING Agonist-Loaded Hollow Polymeric Nanoparticles for Safe and Effective Vaccination against Middle East Respiratory Syndrome Coronavirus.

Authors:  Leon Chien-Wei Lin; Chen-Yu Huang; Bing-Yu Yao; Jung-Chen Lin; Anurodh Agrawal; Abdullah Algaissi; Bi-Hung Peng; Yu-Han Liu; Ping-Han Huang; Rong-Huay Juang; Yuan-Chih Chang; Chien-Te Tseng; Hui-Wen Chen; Che-Ming Jack Hu
Journal:  Adv Funct Mater       Date:  2019-04-12       Impact factor: 18.808

5.  BCG and BCGΔBCG1419c protect type 2 diabetic mice against tuberculosis via different participation of T and B lymphocytes, dendritic cells and pro-inflammatory cytokines.

Authors:  Cristian Alfredo Segura-Cerda; Brenda Marquina-Castillo; Vasti Lozano-Ordaz; Dulce Mata-Espinosa; Jorge Alberto Barrios-Payán; Manuel O López-Torres; Michel de Jesús Aceves-Sánchez; Helle Bielefeldt-Ohmann; Rogelio Hernández-Pando; Mario Alberto Flores-Valdez
Journal:  NPJ Vaccines       Date:  2020-03-12       Impact factor: 7.344

6.  Evaluation of early innate and adaptive immune responses to the TB vaccine Mycobacterium bovis BCG and vaccine candidate BCGΔBCG1419c.

Authors:  Manuja Gunasena; Rajni Kant Shukla; Naiquan Yao; Oscar Rosas Mejia; Michael D Powell; Kenneth J Oestreich; Michel de Jesús Aceves-Sánchez; Mario Alberto Flores-Valdez; Namal P M Liyanage; Richard T Robinson
Journal:  Sci Rep       Date:  2022-07-20       Impact factor: 4.996

7.  BCGΔBCG1419c increased memory CD8+ T cell-associated immunogenicity and mitigated pulmonary inflammation compared with BCG in a model of chronic tuberculosis.

Authors:  Kee Woong Kwon; Michel de Jesús Aceves-Sánchez; Cristian Alfredo Segura-Cerda; Eunsol Choi; Helle Bielefeldt-Ohmann; Sung Jae Shin; Mario Alberto Flores-Valdez
Journal:  Sci Rep       Date:  2022-09-22       Impact factor: 4.996

Review 8.  Intercellular communication and social behaviors in mycobacteria.

Authors:  Seenivasan Boopathi; Subbiah Ramasamy; B Haridevamuthu; Raghul Murugan; Maruthanayagam Veerabadhran; Ai-Qun Jia; Jesu Arockiaraj
Journal:  Front Microbiol       Date:  2022-09-13       Impact factor: 6.064

9.  Vaccination with BCGΔBCG1419c protects against pulmonary and extrapulmonary TB and is safer than BCG.

Authors:  Michel de Jesús Aceves-Sánchez; Mario Alberto Flores-Valdez; César Pedroza-Roldán; Elizabeth Creissen; Linda Izzo; Fabiola Silva-Angulo; Clinton Dawson; Angelo Izzo; Helle Bielefeldt-Ohmann; Cristian Alfredo Segura-Cerda; Wendy López-Romero; Jorge Bravo-Madrigal; Jorge Alberto Barrios-Payán; Miguel Ángel de la Cruz; Miguel Ares; María Guadalupe Jorge-Espinoza
Journal:  Sci Rep       Date:  2021-06-14       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.